Top compounds associated with response to CLDND2


Feature Type Standardized
Nominal ANOVA
mRNA Imatinib CTRPv2 pan-cancer AAC 0.029 0.4
mRNA BIX-01294 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.029 0.4
mRNA BRD-K35604418 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA Tamoxifen CTRPv2 pan-cancer AAC -0.03 0.4
mRNA blebbistatin CTRPv2 pan-cancer AAC 0.06 0.4
mRNA CIL41 CTRPv2 pan-cancer AAC 0.042 0.4
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.027 0.4
mRNA XL765 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.028 0.4
Download CSV